Alrial Natriuretic Factor in Hypertensive and Normotensive Diabetic Patients

  title={Alrial Natriuretic Factor in Hypertensive and Normotensive Diabetic Patients},
  author={Claudio Ferri and Alfonso Piccoli and Oriana Laurenti and C. Bellini and Giancarlo De Mattia and Anna Santucci and Francesco Balsano},
  journal={Diabetes Care},
  pages={195 - 200}
OBJECTIVE To evaluate plasma amai natriuretic factor (ANF) behavior in hypertensive patients with either insulin-dependent (type I) or non-insulin-dependent (type II) diabetes. RESEARCH DESIGN AND METHODS Plasma ANF levels were measured in euglycemic normotensive patients (n = 18) and hypertensive patients (n = 18), in diabetic normotensive patients (type I diabetes, n = 12; type II diabetes, n = 12), and in diabetic hypertensive patients (type I diabetes, n = 12; type II diabetes, n = 22). In… 

Figures and Tables from this paper

Atrial natriuretic peptide increases urinary albumin excretion in people with normoalbuminuric type-2 diabetes

ANP increases UAER in normoalbuminuric type-2 diabetic subjects and the natriuretic response to ANP was similar to diabetic subjects, and hyperglycaemic did not enhance the album inuric response to AnP.

Factors influencing LVM in hypertensive type-1 diabetic patients.

Dietary sodium intake is proposed as an important factor in the development of LVH in hypertensive type-1 diabetic patients and a significant association was found between LVM and blood pressure or albuminuria.

Plasma brain natriuretic peptide levels in normotensive noninsulin-dependent diabetic patients with microalbuminuria.

The increased plasma level of B NP in patients with microalbuminuria and its significant correlation with urinary albumin excretion rate suggest that the elevated circulating levels of BNP are caused by the presence of diabetic nephropathy.

Elevated plasma concentrations of atrial and brain natriuretic peptide in type 1 diabetic subjects

Plasma concentrations of ANP and BNP are elevated in some patients with type 1 diabetes and elevated plasma concentrations are associated with poor glycaemic control and systemic hypertension.

The Effect of Losartan on Plasma Atrial Natriuretic Peptide Levels in the Diabetic Rat Model

Plasma atrial natriuretic peptide levels in diabetic untreated rats were not different from the healthy control group, and this finding may be explained by the inhibition of the renin-angiotensinaldosterone system leading to a reduction of effective plasma volume expansion.

Enhanced albuminuric response to atrial natriuretic peptide in normoalbuminuric patients with Type 1 diabetes mellitus – a pilot study

To ascertain whether intravenous infusion of atrial natriuretic peptide (ANP) can induce microalbuminuria in patients with Type 1 diabetes mellitus (DM) and to compare the albuminuric response to ANP infusion in Type 1 DM and a matched group of healthy non‐diabetic controls.


Down-regulation of A-type guanylate cyclase-coupled receptor of renal tubules may explain the increased plasma levels of both BNP and ANP in normotensive diabetic patients with microalbuminuria.

Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.

The findings suggest a role for ANP in PDR, and suggest intraocular ANP synthesis and/or an increase in the release of ANP into the vitreous, as opposed to diffusion from the blood, as the main factors contributing to the high vitREous ANP levels observed in diabetic patients.

Renal Components of the Hypertensive Syndrome

The incidence of non-insulin-dependent diabetes mellitus is also growing in this group and hypertension in t h e presence of diabetes is associated with a much greater rate of progression to ESRD compared with that with hypertension alone.



Increased plasma atrial natriuretic factor and reduced plasma renin in patients with poorly controlled diabetes mellitus.

Plasma immunoreactive ANF and plasma renin activity (PRA) was measured in 27 non-ketotic diabetic patients without evidence of cardiac or overt renal disease, and compared them with 26 age- and sex-matched normal subjects.

Plasma atrial natriuretic peptide in young normotensive subjects with a family history of hypertension and in young hypertensive patients.

Plasma ANP is raised in young essential hypertensives, resulting in slightly elevated levels in normotensives with hypertensive heredity, and this level is higher in the latter group than in the control group.

Elevated plasma atrial natriuretic peptide level in the early phase of microalbuminuria in patients with non-insulin-dependent diabetes mellitus.

An elevated plasma ANP level in the early phase of microalbuminuria possibly plays a pathophysiological role in the development of nephropathy in NIDDM patients is suggested.

Elevated plasma atrial natriuretic peptide levels in diabetic rats. Potential mediator of hyperfiltration.

It is concluded that elevated endogenous ANP levels contribute to the hyperfiltration observed in early diabetes in the rat.

The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man.

The effect of insulin on CH2O suggests that insulin's effect on sodium excretion is due to enhancement of sodium reabsorption in the diluting segment of the distal nephron, and a reduction in UNaV associated with insulin administration is demonstrated.

Atrial Natriuretic Peptide and Response to Changing Plasma Volume in Diabetic Nephropathy

It is proposed that renal insensitivity to ANP in diabetic nephropathy could contribute to altered vasoreactivity and abnormal excretory responsiveness to changing plasma volume, and blunted natriuresis in response to AnP release and enhanced sodium retention during volume contraction could account for the expanded extracellular fluid volume.

Atrial natriuretic factor in hypertensive diabetic patients

  • Diabetes , Obesity , and Hyperlipidemias
  • 1990

The value of cardiovascolar autonomic function test: 10 years expe- rience in diabetes

  • Diabetes Care 8:491-
  • 1985

KGMM : Hyper- tension in diabetes mellitus: role of insu- lin and atrial natriuretic peptide (Ab- stract)

  • Diabetologia 31:519A,
  • 1988